Key result
Silent pulmonary thromboembolism occurred in 26% of patients undergoing craniotomy for a brain tumor, with no significant correlation to patient or surgical factors.
Why the study?
The frequency of silent pulmonary thromboembolism and its related clinical factors in patients undergoing craniotomy for brain tumors remained to be determined.
What is the frequency of silent pulmonary thromboembolism in patients undergoing craniotomy for brain tumors?
Observational (n=100)
What is the frequency of silent pulmonary thromboembolism in patients undergoing craniotomy for brain tumors?
Silent pulmonary thromboembolism occurs in approximately one-quarter of patients undergoing craniotomy for brain tumors, highlighting a high-risk population for venous thromboembolism.
Answers are grounded in this paper and cite their sources.
Silent PE common after craniotomy; leaves open whether screening improves outcomes in this population.
AIM: To detect the silent pulmonary thromboembolism (SPTE) frequency in patients who underwent craniotomy for a brain tumor, and to examine the correlation based on the data obtained from patients. MATERIAL AND METHODS: Overall, 100 patients with brain tumors were included in the study. The mean age was 54.29 years (±12.5 years), with the youngest patient being 19 years old and the oldest 73 years. All patients underwent craniotomy, and a pulmonary ventilation-perfusion scintigraphy was performed 48 h after surgery to detect SPTE. The frequency of SPTE and the conditions related to it were investigated. RESULTS: The incidence of SPTE was 26% in patients with a brain tumor who underwent craniotomy. Statistically, no correlation was observed between SPTE and data obtained from patients (tumor histopathology, tumor localization, perilesional edema, midline shift, bleeding time, surgical positioning, smoking history, age, duration of surgery, etc.). CONCLUSION: Our study revealed a high rate of SPTE in patients with a brain tumor who underwent craniotomy. Although most articles suggest using anticoagulant therapy in these patients, the literature lacks definite evidence for the same.
No takes yet. Share an insight, caveat, or question.
Gök et al. (2022) conducted an observational in Brain tumor (n=100). Craniotomy for brain tumor was evaluated on Silent pulmonary thromboembolism (SPTE). Silent pulmonary thromboembolism occurred in 26% of patients undergoing craniotomy for a brain tumor, with no significant correlation to patient or surgical factors.
Synapse has enriched 10 related papers. Consider them for comparative context: